The Short Version
The weight of high-quality evidence contradicts this claim. Multiple meta-analyses, umbrella reviews, and clinical studies associate vitamin C with reduced cancer incidence and improved prognosis — not worsened outcomes. The narrow concern about vitamin C interfering with certain chemotherapy drugs has been observed primarily in preclinical and animal studies, not consistently in human trials. The only controlled clinical trial in the evidence base found no harm from high-dose vitamin C, only no benefit — which is not a "negative effect."